Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1CNS 1

Conditions

Neoplasms 8Breast Neoplasms 7Uterine Cervical Neoplasms 6Uterine Cervical Dysplasia 5Persistent Infection 4Melanoma 4Glioblastoma 3Carcinoma, Non-Small-Cell Lung 3Sarcoma 2Neuroblastoma 2Lung Neoplasms 2Influenza, Human 2HIV Infections 2Glioma 2Condylomata Acuminata 2Breast Neoplasms, Male 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Spondylitis, Ankylosing 1Small Cell Lung Carcinoma 1Rheumatic Diseases 1Recurrence 1Psoriasis 1Prostatic Neoplasms 1Papillomavirus Infections 1Pancreatic Neoplasms 1Neuroectodermal Tumors, Primitive 1Neoplasms, Nerve Tissue 1

Interventions

Filgrastim 10Cyclophosphamide 8Granulocyte Colony-Stimulating Factor 6Melphalan 5Busulfan 5Vincristine 4Topotecan 4Temozolomide 4Stem Cell Transplantation 4Peripheral Blood Stem Cell Transplantation 4Ifosfamide 4Etoposide 4Thiotepa 3Radiotherapy 3Mesna 3Itraconazole 3Doxorubicin 3Cisplatin 3Carboplatin 3sargramostim 2fludarabine 2Therapeutics 2Sirolimus 2Radiotherapy, Intensity-Modulated 2Nivolumab 2Drug Therapy 2Bone Marrow Transplantation 2Blood Specimen Collection 2Amplified Fragment Length Polymorphism Analysis 2trioctyl phosphine oxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Wilms Tumor × Vaccines × Clear all
NCT00405327 2017-11-06

A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation

University of Michigan Rogel Cancer Center

Phase 2 Completed
16 enrolled
CNSGenitourinarySarcoma

Neoplasms, Wilms Tumor, Neuroblastoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡